Offer - Urjas Oil for just ₹ 1
Caviter is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Tuberculosis.
The optimal dosage of Caviter is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Caviter also has some side effects, the most common being Rash, Erythema, Discoloration of Urine. Some other side effects of Caviter have been listed ahead. Such side effects of Caviter normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Caviter's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Caviter's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Caviter contraindications section.
Besides this, Caviter may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Caviter is not safe while driving, and is not addiction.
Caviter is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Is the use of Caviter safe for pregnant women?
Caviter can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Caviter right away. Take your doctor's advice before taking it again.
Is the use of Caviter safe during breastfeeding?
Caviter may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Caviter, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Caviter.
What is the effect of Caviter on the Kidneys?
Caviter may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Caviter on the Liver?
There may be an adverse effect on the liver after taking Caviter. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Caviter on the Heart?
The heart can be affected by Caviter. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Caviter should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Caviter unless your doctor advises you to do so -
Is this Caviter habit forming or addictive?
No, there is no any evidence that Caviter is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Caviter can make you feel drowsy.
Is it safe?
Yes, but consume Caviter only on doctor's advice.
Is it able to treat mental disorders?
No, Caviter cannot treat any kind of mental disorder.
Interaction between Food and Caviter
Taking Caviter with food is safe.
Interaction between Alcohol and Caviter
Taking Caviter with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 768-769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1066-1067
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
Product Description [Internet]: RIFATER® (rifampin, isoniazid and pyrazinamide USP). USFDA
Product Description [Internet]: RIFADIN®. USFDA
Product Description [Internet]: ISONIAZID. Alliance Pharmaceuticals Limited
